Espy Anguiano, PhD, is the Scientific Market Development Director for BioPharma at NanoString Technologies. Espy is focused on the successful adoption of spatial technologies in drug development research activities. Espy supports NanoString Technologies' global pharmaceutical and CRO customers representing an install base of over 70 GeoMx Digital Spatial Profiler and 20 CosMx Spatial Molecular Imager platforms across the globe.
Espy obtained her PhD in Biomedical Science from Baylor University and holds a dual business degree (MS-MBA) from Temple University. She has over 20 years of experience in molecular biology and genomics research and is passionate about harnessing innovative technologies and science to understand human disease and advance drug development.
Espy played a leading role in building blood transcriptomics as a tool to study human immune-mediated diseases during her tenure at the Baylor Institute for Immunology Research. As an expert in genome technologies at Bristol-Myers Squibb, she supported many translational and precision medicine biomarker development strategies for multiple immuno-oncology and immunology clinical programs. She also led the translational sciences activities assessing spatial biology methods.